Nashua, NH
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)National PERT Consortium Inc, founded in 2015, is a community nonprofit in the Medical Research sector that reported $2.0M in total revenue in fiscal year 2023. Expenses of $1.8M left a modest 13% surplus.
The Organization seeks to coordinate and expedite the treatment of pulmonary embolus with a balanced team of physicians from a variety of specialties. This multi-disciplinary approach allows for the rapid evaluation of risks, formulation of a treatment plan, and mobilization of resources.
The Organization holds an annual National PERT Symposium and business meeting to (a) educate the medical community on the latest advances in the diagnosis, risk stratification and treatment of PE...
The Organization holds an annual National PERT Symposium and business meeting to (a) educate the medical community on the latest advances in the diagnosis, risk stratification and treatment of PE, (b) explore the science behind PE diagnosis and treatment, (c) share knowledge regarding PE management, (d) provide a forum for presentation of novel approaches to PE management as they arise, (e) recognize the potential complications from PE and how to prevent and treat them, (f) highlight unique patient populations and their specific treatment challenges, (g) promote and enhance coordinated, multidisciplinary care of PE patients, and (h) explore opportunities for quality improvement in PE management.(Continued on Schedule O)The Organization also presents satellite education symposia in partnership with existing peer organization conferences to (a) increase awareness of PE among providers for improving detection and management, (b) promote the concept of team-based management for PE (and PERTs specifically), (c) inform attendees of the latest options for patients with PE, (d) promote best practices and high-quality care for PE, and (e) encourage joining the Organization and participating in the PERT quality assurance database, educational programs, roundtables and other PERT activities.
The Organization has established a comprehensive database, coalescing data from all participating PERT sites (anticipated to be more than 75 sites within two years), a large high-quality dataset...
The Organization has established a comprehensive database, coalescing data from all participating PERT sites (anticipated to be more than 75 sites within two years), a large high-quality dataset, coordinated and owned by the organization (with data from each site owned by organization and the pert site). The database will allow sites to (a) enable quality improvement and benchmarking for individual institutions and practitioners to evaluate their own data (self-assessment), (b) compare their strategy and outcomes to treatment algorithms and combined outcomes at other sites, (c) utilize the information to improve/update practices at their own institution, and (d) access a large dataset to facilitate analysis and evaluate efficacy of various approaches and treatment modalities for PE (continued on Schedule O).Access to the database and its wealth of information is one of the multiple benefits that Member Institutions can take advantage of; membership value proposition is to gain support from others who support the Organization's mission at various levels and includes but is not limited to sponsorship opportunities, participation in special educational projects, membership on certain committees of the Organization and attendance to the annual Symposium event. Additionally, the Organization may generate program fees from collaborative PERT-related research agreements with unrelated entities. The Organization's research furthers the field of PE knowledge and promotes enhanced care and information.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,029,016 | $1,911,088 | +0.1% |
| Expenses | $1,763,168 | $1,681,711 | +0.0% |
| Net Income | $265,848 | $229,377 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Lauren Baker PhD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Richard Channick MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Wissam Jaber MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| James Horowitz MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Menno Huisman MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Scott Kaatz MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Brent Keeling MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Ted Killory | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Andrew Klein MD | Director (part year) | 1.00 |
Director
|
$0 | $0 | $0 |
| Stavros Konstantnides | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Matt Langston MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Robert Lookstein MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Michael McDaniel MD | Director (part year) | 1.00 |
Director
|
$0 | $0 | $0 |
| Soophia Naydenov MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Kate Ardini Oldfield | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Steve Pugilese MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Mona Ranade MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Ken Rosenfield MD | Director (part year) | 1.00 |
Director
|
$0 | $0 | $0 |
| Juli Gardner Spencer | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Seth Sokol MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Dean Stratouly | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Mae West MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Alison Witkin MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| John Moriarty | Board President Elect | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Rachel Rosovsky MD | Board President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Amy Ranier | Board Chair | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Roy Smith MD | Board Chair (part year) | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Mahir Elder MD | Board Vice President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Tom Todoran MD | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Michelle Lanno | Executive Director | 40.00 |
Officer
|
$335,405 | $1,080 | $336,485 |
| Jamie Lynn Reed | Project Manager | 40.00 |
Highest
|
$126,773 | $600 | $127,373 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,029,016 | $1,763,168 | $2,055,637 | $265,848 |
| 2022 | $1,911,088 | $1,681,711 | $2,417,862 | $229,377 |
| 2021 | $1,418,986 | $1,124,655 | $1,510,902 | $294,331 |
| 2020 | $1,122,933 | $1,007,660 | $690,403 | $115,273 |
| 2019 | $769,613 | $827,589 | $584,263 | $-57,976 |
| 2018 | $1,251,432 | $1,084,803 | $518,693 | $166,629 |
| 2017 | $851,189 | $680,036 | $306,167 | $171,153 |
Compare National PERT Consortium Inc with other nonprofits in New Hampshire and across the country.